Serum backed Mylab to make and sell Covid-19 vax, working on 2-3 platforms

Partners with Shilpa Medicare to manufacture vaccines, therapeutics

Pune-based Mylab Discovery Solutions, a diagnostics solutions provider, is now foraying into manufacturing and marketing vaccines as a part of its forward integration plans. The firm backed by India’s leading vaccine maker Serum Institute of India (SII), is working on two or three technology platforms for Covid19 vaccines, and would start production at its partner Shilpa Biological’s Dharwad site in March.

Moreover, the company has plans to make therapeutics too.

Speaking to Business Standard Mylab’s MD Hasmukh Rawal said that they are now doing a viability or feasibility study to determine the scale of production, any gap analysis etc. Shilpa